Oragenics, Inc.’ CEO To Present at the Rodman & Renshaw Annual Global Investment Conference

Published: Sep 10, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (OTCQB: ORNI) (the “Company”) a world leader in oral health probiotics and systemic antibiotics, announced today that John N. Bonfiglio, President and CEO of Oragenics, will be presenting an update of the Company at the Rodman and Renshaw Annual Global Investment Conference September 9-11th, 2012. Dr. Bonfiglio is scheduled to speak on Monday September 10th at 3:15 pm.

Back to news